Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Whey protein before carbs may tame pregnancy blood sugar

NCT ID NCT06170905

Symptom relief Sponsor: University of Ulm Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study looked at whether drinking whey protein before eating carbohydrates could help control blood sugar spikes in pregnant women. Twenty-one pregnant women without diabetes took part. They had glucose tests with and without whey protein to compare blood sugar and insulin levels.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

21 people

The number who actually took part.

Started

Feb 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women between 24+0 and 27+6 (+/- 7 days) weeks of pregnancy after menstruation * BMI before pregnancy: 18 - 29.9 kg/m2 * No known underlying diseases * Understanding and voluntary signing of a consent form before study-related examinations Exclusion Criteria: * Age \< 18 years * Diabetes mellitus type 1 or type 2 * Drug therapy that raises or lowers blood sugar, e.g. steroids, antidiabetics, insulin. * Endocrine disorders (e.g. hyperthyroidism, polycystic ovary syndrome (PCOS), ...) * Current depression or other mental illnesses * Eating disorder * Regular intake of medication other than vitamins/trace elements during pregnancy * Estimated glomerular filtration rate (eGFR) \< 60 ml/min/1.73 m² * C-reactive protein \> 10 mg/l * Transaminase elevation of 2 times the upper norm * Pre-existing cardiac diseases * Drug and/or alcohol abuse * Hb \< 12 g/dl * No consent to be informed about incidentally discovered pathological findings * Any other (clinical) condition that would endanger participants safety or question scientific success according to the physicians opinion.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postprandial glycemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gestational diabetes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Postprandial glycemia Pregnancy

Contacts and locations

Locations

  • Universityhospital Ulm

    Ulm, 89081, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.